298. Hereditary pancreatitis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 110 / Drugs : 142 - (DrugBank : 59) / Drug target genes : 61 - Drug target pathways : 154
Hereditary pancreatitis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 298 | Hereditary pancreatitis | - |
| 13 | Multiple sclerosis | 37.764 |
| 6 | Parkinson disease | 36.742 |
| 46 | Malignant rheumatoid arthritis | 32.310 |
| 97 | Ulcerative colitis | 31.508 |
| 96 | Crohn disease | 31.090 |
| 70 | Spinal stenosis | 30.751 |
| 36 | Epidermolysis bullosa | 23.640 |
| 231 | Alpha-1-antitrypsin deficiency | 22.594 |
| 140 | Dorabe syndrome | 21.205 |
| 144 | Lennox-Gastaut syndrome | 21.053 |
| 193 | Prader-Willi syndrome | 20.767 |
| 156 | Rett syndrome | 19.595 |
| 2 | Amyotrophic lateral sclerosis | 18.082 |
| 158 | Tuberous sclerosis | 17.220 |
| 272 | Fibrodysplasia ossificans progressiva | 17.126 |
| 34 | Neurofibromatosis | 16.713 |
| 152 | PCDH19 related syndrome | 16.000 |
| 84 | Sarcoidosis | 15.819 |
| 8 | Huntington disease | 15.723 |
| 145 | West syndrome | 15.389 |
| 98 | Eosinophilic gastro-intestinal disorder | 14.815 |
| 22 | Moyamoya disease | 13.755 |
| 205 | Fragile X syndrome related disease | 13.305 |
| 206 | Fragile X syndrome | 13.252 |
| 201 | Angelman syndrome | 12.954 |
| 21 | Mitochondrial disease | 12.846 |
| 18 | Spinocerebellar degeneration | 11.958 |
| 3 | Spinal muscular atrophy | 11.181 |
| 155 | Acquired aphasia with convulsive disorder | 10.993 |
| 296 | Biliary atresia | 10.868 |
| 75 | Cushing disease | 10.547 |
| 226 | Interstitial cystitis with Hunners ulcer | 10.430 |
| 51 | Scleroderma | 9.751 |
| 5 | Progressive supranuclear palsy | 9.405 |
| 17 | Multiple system atrophy | 7.760 |
| 86 | Pulmonary arterial hypertension | 7.416 |
| 10 | Charcot-Marie-Tooth disease | 6.148 |
| 58 | Hypertrophic cardiomyopathy | 5.846 |
| 107 | Juvenile idiopathic arthritis | 5.642 |
| 271 | Ankylosing spondylitis | 5.434 |
| 38 | Stevens-Johnson syndrome | 4.830 |
| 113 | Muscular dystrophy | 3.908 |
| 81 | Congenital adrenal hyperplasia | 3.340 |
| 299 | Cystic fibrosis | 3.282 |
| 28 | Systemic amyloidosis | 3.116 |
| 168 | Ehlers-Danlos syndrome | 2.987 |
| 256 | Muscle glycogenosis | 2.960 |
| 50 | Dermatomyositis | 2.929 |
| 53 | Sjogren syndrome | 2.751 |
| 1 | Spinal and bulbar muscular atrophy | 2.736 |
| 251 | Urea cycle disorder | 2.292 |
| 85 | Idiopathic interstitial pneumonia | 2.208 |
| 222 | Primary nephrotic syndrome | 2.098 |
| 43 | Microscopic polyangiitis | 2.089 |
| 337 | Homocystinuria | 2.000 |
| 282 | Congenital dyserythropoietic anemia | 2.000 |
| 19 | Lysosomal storage disease | 1.995 |
| 65 | Primary immunodeficiency | 1.811 |
| 167 | Marfan syndrome | 1.781 |
| 45 | Eosinophilic granulomatosis with Polyangiitis | 1.730 |
| 114 | Non-dystrophic myotonia syndrome | 1.730 |
| 41 | Giant cell arteritis | 1.647 |
| 15 | Inclusion body myositis | 1.647 |
| 67 | Polycystic kidney disease | 1.519 |
| 35 | Pemphigus | 1.501 |
| 127 | Frontotemporal lobar degeneration | 1.477 |
| 40 | Takayasu arteritis | 1.377 |
| 310 | Congenital anomalies syndrome | 1.358 |
| 42 | Polyarteritis nodosa | 1.343 |
| 49 | Systemic lupus erythematosus | 1.298 |
| 300 | IgG4-related disease | 1.288 |
| 225 | Congenital nephrogenic diabetes insipidus | 1.226 |
| 56 | Behcet disease | 1.101 |
| 95 | Autoimmune hepatitis | 1.080 |
| 94 | Primary sclerosing cholangitis | 1.080 |
| 235 | Hypoparathyroidism | 1.038 |
| 71 | Idiopathic osteonecrosis of the femoral head | 1.038 |
| 44 | Wegener granulomatosis | 1.006 |
| 220 | Rapidly progressive glomerulonephritis | 1.000 |
| 30 | Distal myopathy | 1.000 |